Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer

Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 18; no. 12; pp. 2045 - 2046
Main Authors: Muñoz, A., Carrera, S., Ferreiro, J., Ruiz de Lobera, A., Mañé, J.M., López-Vivanco, G.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-12-2007
Oxford University Press
Oxford Publishing Limited (England)
Subjects:
Adult
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Breast Neoplasms - drug therapy
Chemotherapy, Adjuvant
Female
Hemochromatosis Protein
Histocompatibility Antigens Class I - genetics
Humans
Immunohistochemistry
Liver - drug effects
Membrane Proteins - genetics
Point Mutation
Receptor, ErbB-2 - metabolism
Trastuzumab
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:istex:2B683DD36C106C7255A82079D45DF4C62D344DDB
ark:/67375/HXZ-VHK2L8HF-S
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdm515